1. Asoh, Y., Tsuruoka, H., Hayashi, N., Yoshida, J., Aoki, K., Homma, T., Arai, K., in preparation. Discovery of novel atropisomerism in CS-3150 as a potent non-steroidal mineralocorticoid receptor antagonist. Unpublished results.
2. Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases;Bärfacker;ChemMedChem,2012
3. Canne, B.L., Chen, J., Dalrymple, L.E., Flatt, B.T., Forsyth, T.P., Gu, X.H., Mac, M.B., Mann, L.W., Mann, G., Martin, R., Mohan, R., Murphy, B., Nyman, M.C., Stevens, W.C., Jr., Wang, T.L., Wong, Y., Wu, J.H., 2006. WO Patent no. WO2006/012642.
4. Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist;Casimiro-Garcia;J. Med. Chem.,2014
5. Cardiovascular outcomes in patients with primary aldosteronism after treatment;Catena;Arch. Intern. Med.,2008